| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/16/2013 | US8420676 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes Torezolid phosphate |
| 04/16/2013 | US8420675 Aminotetrahydroindazoloacetic acids |
| 04/16/2013 | US8420674 Method of providing pirfenidone therapy to a patient |
| 04/16/2013 | US8420673 Fungicidal amides |
| 04/16/2013 | US8420672 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindo1-2-yl)-piperidine-2,6-dione and methods of making the same |
| 04/16/2013 | US8420671 Stabilised thiophene derivatives |
| 04/16/2013 | US8420670 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 04/16/2013 | US8420669 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor |
| 04/16/2013 | US8420668 1-(2H)-isoquinolone derivative |
| 04/16/2013 | US8420667 Isoquinolinone derivatives as NK3 antagonists |
| 04/16/2013 | US8420666 Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors |
| 04/16/2013 | US8420665 Anti-cancer compounds |
| 04/16/2013 | US8420664 A3 adenosine receptor allosteric modulators |
| 04/16/2013 | US8420663 Peripheral opioid receptor antagonists and uses thereof |
| 04/16/2013 | US8420662 Stable solid preparation containing 4,5-epoxymorphinan derivative |
| 04/16/2013 | US8420661 Arylethynyl derivatives |
| 04/16/2013 | US8420660 Antitubercular alkaloid |
| 04/16/2013 | US8420659 Compositions and methods for inhibition of the JAK pathway |
| 04/16/2013 | US8420658 Use of Carboxyamidotriazole (CAI) orotate in macular degeneration |
| 04/16/2013 | US8420657 Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors |
| 04/16/2013 | US8420655 Benzimidazole inhibitors of leukotriene production |
| 04/16/2013 | US8420654 1,5-Diphenyl-pyrrolidin-2-one compounds as CB-1 ligands |
| 04/16/2013 | US8420652 Use of aryl piperazine derivatives in manufacturing medicants for treating pain |
| 04/16/2013 | US8420651 Substituted 1-alkylcinnolin-4(1H)-one derivatives, preparation thereof and therapeutic application of same |
| 04/16/2013 | US8420650 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 04/16/2013 | US8420649 Pyrido[3,2-d]pyridazine-2(1H)-one compounds as p38 modulators and methods of use thereof |
| 04/16/2013 | US8420648 Polymorphs of brimonidine pamoate |
| 04/16/2013 | US8420647 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 04/16/2013 | US8420646 Tricyclic tetrahydroquinoline antibacterial agents |
| 04/16/2013 | US8420645 Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| 04/16/2013 | US8420644 Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas |
| 04/16/2013 | US8420643 Compounds and method for treatment of cancer |
| 04/16/2013 | US8420642 Pyridine derivatives useful as glucokinase activators |
| 04/16/2013 | US8420641 Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives |
| 04/16/2013 | US8420640 Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine |
| 04/16/2013 | US8420639 Arylsulfonamide CCR3 antagonists |
| 04/16/2013 | US8420638 Triheterocyclic compounds and compositions thereof |
| 04/16/2013 | US8420637 Abnormal cannabidiols as agents for lowering intraocular pressure |
| 04/16/2013 | US8420636 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as CCR3 receptor ligands |
| 04/16/2013 | US8420635 Method for preventing or treating a glucocorticoid receptor-related disease |
| 04/16/2013 | US8420634 Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies |
| 04/16/2013 | US8420633 Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 04/16/2013 | US8420632 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 04/16/2013 | US8420631 Serotonin receptor antagonist; therapy for obesity, antidepressants, obsessive-compulsive disorders |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420629 Azetidine and cyclobutane derivatives as JAK inhibitors |
| 04/16/2013 | US8420628 Substituted beta-lactams |
| 04/16/2013 | US8420627 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria |
| 04/16/2013 | US8420626 Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof |
| 04/16/2013 | US8420625 Lipolytic methods for regional adiposity |
| 04/16/2013 | US8420624 Methods for treating or preventing symptoms of hormonal variations |
| 04/16/2013 | US8420623 N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 04/16/2013 | US8420622 Silylated piperidine derivatives |
| 04/16/2013 | US8420621 Methods of using gamma cyclodextrin to control blood glucose and insulin secretion |
| 04/16/2013 | US8420620 Induced internalization of surface receptors |
| 04/16/2013 | US8420617 Multiantivirus compound, composition and method for treatment of virus diseases |
| 04/16/2013 | US8420616 MAT II beta subunit RNAi and therapeutic methods using same |
| 04/16/2013 | US8420610 Polyunsaturated compounds, method for preparing same and compositions containing the same |
| 04/16/2013 | US8420609 Stable needle-shaped crystals of natamycin |
| 04/16/2013 | US8420607 Anthrax carbohydrates, synthesis and uses thereof |
| 04/16/2013 | US8420606 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
| 04/16/2013 | US8420603 SPARC and methods of use thereof |
| 04/16/2013 | US8420601 Biocompatible materials containing stable complexes of TSG-6 and hyaluronan and method of using same |
| 04/16/2013 | US8420600 Relieving pain at a body site by administering a dosage of capsaicinoid at the painful site without eliciting an effect outside the discrete location; local anesthetic effect; targeted therapy |
| 04/16/2013 | US8420595 Methods for treating acute acoustic trauma |
| 04/16/2013 | US8420593 Compositions and methods for regulating membrane potential |
| 04/16/2013 | US8420572 Fungicidal composition containing carboxylic acid amide derivative |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420391 RNA sequence-specific mediators of RNA interference |
| 04/16/2013 | US8420350 Glycosylation-deficient hepatocyte growth factor |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420133 Modified pectins, compositions and methods related thereto |
| 04/16/2013 | US8420130 Pharmaceutical formulation of a didemnin compound |
| 04/16/2013 | US8420125 Medical food or nutritional supplement for managing blood glucose levels and method of manufacturing same |
| 04/16/2013 | US8420123 Drug loaded polymeric nanoparticles and methods of making and using same |
| 04/16/2013 | US8420122 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| 04/16/2013 | US8420121 Drug delivery vehicles, methods of manufacture, and methods of use thereof |
| 04/16/2013 | US8420120 Oral drug delivery system |
| 04/16/2013 | US8420119 Drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic |
| 04/16/2013 | US8420117 Patch formulation for external use |
| 04/16/2013 | US8420115 Oral preparations and process for production thereof |
| 04/16/2013 | US8420114 Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
| 04/16/2013 | US8420112 Solid dosage form for treating headaches |
| 04/16/2013 | US8420111 Method and kit for reducing the symptoms of peripheral vascular disease |
| 04/16/2013 | US8420075 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 04/16/2013 | US8420069 Antimicrobial and antifouling polymeric materials |
| 04/16/2013 | US8420068 Polymer-based compositions and conjugates of antimicrobial agents |
| 04/16/2013 | US8420067 Targeted polylysine dendrimer therapeutic agent |
| 04/16/2013 | US8420060 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
| 04/16/2013 | US8419971 Method for producing mechanically stable water-absorbent polymer particles |
| 04/16/2013 | CA2749579C 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester-methanesulphonate and use thereof as a medicament |
| 04/16/2013 | CA2723494C 2-methyl piperazine derivatives for treatment of serotonin-related disorders |
| 04/16/2013 | CA2712228C 4,5-dihydro-oxazol-2-yl amine derivatives |
| 04/16/2013 | CA2703831C Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 04/16/2013 | CA2637204C Substituted quinolones iii |
| 04/16/2013 | CA2577938C Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 04/16/2013 | CA2576531C 1,5-diphenylpyrazoles |
| 04/16/2013 | CA2566655C Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 04/16/2013 | CA2559128C Kinase inhibitors |
| 04/16/2013 | CA2555248C Use of 2,5 dihydroxybenzenesulfonic acid, in the manufacturing of medicines, applicable to the treatment of angiodependent diseases |